Pharmacokinetics and Safety of Cefazolin 2g in DUPLEX

NCT01121354 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Infection

Interventions

DRUG: Cefazolin 2g for Injection USP and Dextrose Injection USP
DRUG: Cefazolin 1.5g

Sponsor

B. Braun Medical Inc.

Collaborators

[object Object]